PX vs MBRX
Comparison between P10, Inc. (PX, Company) and Moleculin Biotech Inc (MBRX, Company).
PX is from the Financial Services sector, while MBRX is from the Healthcare sector.
PX vs MBRX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
PX
$15M
Winner
MBRX
$15M
Max Drawdown
PX
N/A
MBRX
99.99%
Sharpe Ratio
PX
N/A
MBRX
-0.61
5Y Beta
PX
N/A
MBRX
1.92
Industry
PX
Asset Management
MBRX
Biotechnology
P/E Ratio
PX
0.83
Winner
MBRX
-0.11
Forward P/E
PX
8.06
MBRX
N/A
PEG Ratio
PX
0.00
Winner
MBRX
-0.01
Dividend Yield
PX
1.38%
MBRX
N/A
5Y EPS CAGR
PX
N/A
MBRX
-27.22%
Debt to Equity
PX
92.98%
Winner
MBRX
0.00%
PX vs MBRX - Historical Returns
Returns include dividend reinvestment.
1M
PX
N/A
MBRX
+37.80%
3M
PX
N/A
MBRX
+38.46%
6M
PX
N/A
MBRX
-24.80%
1Y
PX
N/A
MBRX
-80.24%
5Y(CAGR)
PX
N/A
MBRX
-70.90%
10Y(CAGR)
PX
N/A
MBRX
-57.51%
Max(CAGR)
PX
N/A
MBRX
-58.12%
PX vs MBRX - Annual Returns (2016 - 2026)
Returns include dividend reinvestment.
| Year | PX | MBRX |
|---|---|---|
| 2026 | +0.00% | -20.44% |
| 2025 | N/A | -92.52% |
| 2024 | N/A | -87.74% |
| 2023 | N/A | -19.78% |
| 2022 | N/A | -44.21% |
| 2021 | N/A | -63.53% |
| 2020 | N/A | -13.36% |
| 2019 | N/A | -18.30% |
| 2018 | N/A | -43.17% |
| 2017 | N/A | -9.27% |
| 2016 | N/A | -71.50% |
PX vs MBRX Drawdown Comparison
The maximum drawdown for MBRX was -99.99%, occurring on Mar 9, 2026. This drawdown has not yet recovered.
The current MBRX drawdown is -99.99%.
| Rank | PX | MBRX |
|---|---|---|
| #1 | N/A | -99.99% Jun 3, 2016 - Mar 9, 2026 |
Correlation
Correlation between PX and MBRX is 0.00 which considered as a very weak or no correlation - the stocks move independently of each other.
0.00
-101
Select Stocks to Compare
Popular: PX vs SPYMBRX vs SPY
More Comparisons
Compare with similar stocks